|
|
|
|
|
|
The pharmaceutical sector is the engine room that drives clinical trial activity and the benefits that go way beyond patient care. Clinical research delivers significant economic growth, and the European Union has the potential to deliver so much more. That’s why it’s good news that the European Medicines Agency (EMA), alongside the European Commission and Heads of Medicines Agencies (HMA), have set a new target for increasing clinical trials in the EU. The 11.1 percent target should bring an additional 500 multinational trials over five years.
|
|||||
|
|
Patients in Central and Eastern Europe (CEE) have, for many years, faced an uneven playing field in access to medicines. While some countries in this region have made progress in improving the investment in health and modernising their healthcare systems, differences in access to innovative treatments and consequently in health outcomes and life expectancy continues to persist and requires sustained attention. Closing this gap is not only a healthcare priority, but an economic and social necessity. In a study commissioned by EFPIA, academic experts from the CEE region highlight this dual reality of progress alongside remaining gaps for healthcare systems. Read the full report here.
|
|
|
In an executive interview, Fina Lladós, President of Farmaindustria and General Manager of Amgen Iberia, focused on Europe’s pharma competitiveness. ➡️ Watch the full interview here.
|
|
|
European Pharmaceutical Law Forum
Brussels, Belgium
The European pharmaceutical market is facing a moment of profound change. With sweeping updates to the EU pharmaceutical... Learn more → |
|||
|
European Conference on Rare Diseases and Orphan Products (ECRD) 2026
Prague & Online
The next ECRD will be held on 3 & 4 June 2026 in Prague and will be titled “Rare Diseases in a Changing & Competitive... Learn more → |
|||
|
|
The European Health Data Space (EHDS): Breakthrough moment in sharing health data
13 April 2026 (DIA Global Forum)
The EHDS is a new piece of European law, forming part of a growing regulatory and policy ecosystem for digital and...
|
|
Medicines: let’s not wait for the presidential election!
09 April 2026 (POLITICO)
Investing in medicines means investing in health, innovation, and the economy—it is a strategic choice to ensure...
|
|
Greece steps up clinical trial reforms as industry calls for stronger incentives
09 April 2026 (Euractiv)
Despite measurable gains, the Greek pharma industry warns the country's clinical trial ecosystem still needs stronger...
|
|
The next pandemic: prepare now or pay later
09 April 2026 (Vaccines Today)
Experts say the world must be ready to develop and authorise safe, effective and accessible vaccines within 100 days....
|
|
|||
|
|||||
|
EFPIA 2026 All rights reserved ·
Disclaimer
·
|